Examining Different Methods to Assess Busulfan Exposure in Pediatric Hematopoietic Stem Cell Transplant Recipients
When switching between NCA and MBMs to estimate busulfan AUC cum in pediatric HSCT recipients, a change in the target AUC cum is likely required to maintain a similar drug exposure during therapeutic drug monitoring.
Authors
- Rachael Lawson (ORCID: https://orcid.org/0000-0002-0104-5396)
- Christopher Fraser
- Stefanie Hennig (ORCID: https://orcid.org/0000-0001-5972-3711)
- Christine E. Staatz (ORCID: https://orcid.org/0000-0002-4595-9376)
Institutions
- Queensland University of Technology (AU)
- The University of Queensland (AU)
- Children's Health Queensland Hospital and Health Service (AU)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1097/ftd.0000000000001304
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00